Intravitreous Recombinant Tissue Plasminogen Activator and Gas to Treat Submacular Hemorrhage in Age-related Macular Degeneration

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 12, 2003, Pages 608-615

  Tsai, San Chang ^a   Lin, Jane Ming ^a   Chen, Hsin Yi ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Age related macular degeneration; Recombinant tissue plasminogen activator; Submacular hemorrhage

Indexed keywords

ALTEPLASE; OCTAFLUOROPROPANE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; SIDE EFFECT; SUPINE POSITION; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 0345763454     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70514-5     Document Type: Article

References (33)

1. Chaudhry NA, Mieler WF, Han DP, et al. Preoperative use of tissue plasminogen activator for large submacular hemorrhage. Ophthalmic Surg Lasers 1999;30:176-80.
2. Krepler K, Kruger A, Tittl M, et al. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Retina 2000;20:251-6.
3. Chen WL, Liu JH, Lee FL. Natural course of submacular hemorrhage. Chin Med J (Taipei) 1999;62:268-77.
4. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-93. Erratum in: Am J Ophthalmol 1996;122:920.
5. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-93. Erratum in: Am J Ophthalmol 1996;122:920.
6. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-9.
7. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with submacular hemorrhage. Am J Ophthalmol 1990;109:33-7.
8. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97-102.
9. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
10. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-9.
11. Lim JI, Drews-Botsch C, Sternberg P Jr, et al. Submacular hemorrhage removal. Ophthalmology 1995;102:1393-9.
12. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996;121:267-75.
13. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye 1995;9:582-8.
14. Hesse L, Meitinger D, Schmidt J. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration. Ger J Ophthalmol 1996;5:479-83.
15. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefes Arch Clin Exp Ophthalmol 1999;237:10-5.
16. Haupert CL, McCuen BW 2nd, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 2001;131:208-15.
17. Herriot WJ. Intravitreal gas and TPA: an outpatient procedure for subretinal hemorrhage. Presented at the Vail Vitrectomy Meeting, March 10-15, 1996.
18. Hesse L, Schroeder B, Heller G, Kroll P. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage. Retina 2000;20:500-5.
19. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001;108:1485-92.
20. Handwerger BA, Blodi BA, Chandra SR, et al. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 2001;119:28-32.
21. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-7.
22. Leguay J, Gastaud P. Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas. J Fr Ophthalmol 2000;23:797-801. [French]
23. Meier P, Zeumer C, Jochmann C, Wiedemann P. Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection. Ophthalmologe 1999;96:643-7. [German]
24. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-7.
25. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-73.
26. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 1991;11:250-8.
27. el Baba F, Jarrett WH 2nd, Harbin TS Jr, et al. Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology 1986;93:1581-92.
28. Koshibu A, Kaga N, Ohkuma H, et al. Ultrastructural studies on the absorption of experimentally produced subretinal hemorrhage. Folia Ophthalmologica Japonica 1978;29:20-7. [Japanese]
29. Coll GE, Sparrow JR, Marinovic A, Chang S. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina 1995;15:319-26.
30. Boone DE, Boldt HC, Ross RD, et al. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina 1996;16:518-24.
31. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-63.
32. Hrach CJ, Johnson MW, Hassan AS, et al. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 2000;118:659-63.
33. Ohji M, Saito Y, Hayashi A, et al. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Opthalmol 1998;116:1326-32.